# Celldex Therapeutics, Inc.: Form 8-K, filed Jun 14, 2018

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2018-06-14
- Accepted by EDGAR: Jun 14, 2018, 16:01 ET
- Period: 2018-06-13
- Accession: 0001104659-18-040165
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465918040165/a18-15399_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465918040165/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465918040165/a18-15399_18k.htm

Filed Jun 14, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-040165. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
